Valuation — not yet established
No valuation for Chimeron Bio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($18.1M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Chimeron Bio
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2024 | Early Stage VC | $12.8M | ▮ | ▮ |
| Oct 2022 | Debt | $1.2M | ▮ | ▮ |
| Feb 2022 | Debt | $782K | ▮ | ▮ |
| Dec 2020 | Seed Round | $300K | ▮ | ▮ |
How Chimeron Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Chimeron Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Chimeron Bio raised?
- Chimeron Bio has raised $18.1M in total funding across 4 recorded rounds.
- When did Chimeron Bio last raise?
- Chimeron Bio last raised in Mar 2024 (Early Stage VC), raising $12.8M.